OrvigoMax
Natural health product licensed in Canada
- Licence holder
- Platinum Success, LLC dba Niwali
- NPN or DIN-HM
- 80050768
- Status
- Inactive licence
- Licence date
- 12 May 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Turnera diffusa Willd. ex Schult.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Piper nigrum Source : Fruit Potency : 95 % Piperine | 7 mg | Not calculated |
| Trichilia catigua Source : Écorce âgée Extraction ratio : 4:1 Dry plant equivalent : 132 mg | 33 mg | Not calculated |
| Lepidium meyenii Source : Racine | 115 mg | Not calculated |
| Lepidium meyenii Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 460 mg | Not specified | Not calculated |
| Turnera diffusa Source : Feuille | 33 mg | Not calculated |
| Cuscuta chinensis Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 35 mg | 7 mg | Not calculated |
| Tribulus terrestris Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 28 mg | 7 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose microcristalline, Carbonate de calcium, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 day |
Uses authorised in Canada
Panax ginseng is used in Herbal Medicine to help enhance physical capacity/performance (in cases of physical stress). Panax ginseng helps support cognitive function and/or reduce mental fatigue (in cases of mental stress). Maca provides antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80050768
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.